{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:41:09Z","timestamp":1770727269833,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007174","name":"Pfizer Inc Boulder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.12.025","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T17:52:48Z","timestamp":1640800368000},"page":"568-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants"],"prefix":"10.1016","volume":"40","author":[{"given":"Yaniv","family":"Faingelernt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-1046","authenticated-orcid":false,"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart Adriaan","family":"van der Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalom","family":"Ben-Shimol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-3707","authenticated-orcid":false,"given":"Eilon","family":"Shany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2021.12.025_b0005","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMra067279","article-title":"Chronic lung disease after premature birth","volume":"357","author":"Baraldi","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.025_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/2047-783X-16-5-223","article-title":"Respiratory symptoms in preterm infants: burden of disease in the first year of life","volume":"16","author":"Pramana","year":"2011","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1651-2227.2011.02404.x","article-title":"Rehospitalization in the first 2 years of life in children born preterm","volume":"101","author":"Ralser","year":"2012","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2021.12.025_b0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/INF.0000000000000130","article-title":"Increased risk for respiratory syncytial virus-associated, community-acquired alveolar pneumonia in infants born at 31\u201336 weeks of gestation","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2021.12.025_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/INF.0000000000000993","article-title":"population-based analysis of bronchiolitis epidemiology in Valencia","volume":"35","author":"Mu\u00f1oz-Quiles","year":"2016","journal-title":"Spain. Pediatr Infect Dis J"},{"issue":"2-3","key":"10.1016\/j.vaccine.2021.12.025_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/IR:22:2-3:177","article-title":"T cell immunity in neonates","volume":"22","author":"Garcia","year":"2000","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jri.2011.01.022","article-title":"Innate immune cell recruitment in the fetus and neonate","volume":"90","author":"Nussbaum","year":"2011","journal-title":"J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/14767058.2010.482605","article-title":"Innate immunity in human newborn infants: prematurity means more than immaturity","volume":"24","author":"Strunk","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"10.1016\/j.vaccine.2021.12.025_b0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.inf.0000243777.01375.5b","article-title":"A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children","volume":"25","author":"Dennehy","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.025_b0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-3476(96)80131-4","article-title":"Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children","volume":"128","author":"Langkamp","year":"1996","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.025_b0055","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cell.2018.06.045","article-title":"Stereotypic immune system development in newborn children","volume":"174","author":"Olin","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.vaccine.2021.12.025_b0060","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jama.2020.12316","article-title":"Association of routine infant vaccinations with antibody levels among preterm infants","volume":"324","author":"Rouers","year":"2020","journal-title":"JAMA"},{"issue":"9693","key":"10.1016\/j.vaccine.2021.12.025_b0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.vaccine.2021.12.025_b0070","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2015.06.062","article-title":"Impact of PCV7\/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years","volume":"33","author":"Greenberg","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.025_b0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben Shimol","year":"2016","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/ciy842","article-title":"Invasive pneumococcal disease in UK children <1 year of age in the post-13-valent pneumococcal conjugate vaccine era: what are the risks now?","volume":"69","author":"Kent","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.025_b0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"27","key":"10.1016\/j.vaccine.2021.12.025_b0090","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.12.025_b0095","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies","volume":"83","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/ciz768","article-title":"Use of chest radiography examination as a probe for pneumococcal conjugate vaccine impact on lower respiratory tract infections in young children","volume":"71","author":"Ben-Shimol","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.12.025_b0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/INF.0000000000002639","article-title":"Unique features of hospitalized children with alveolar pneumonia suggest frequent viral-bacterial coinfections","volume":"39","author":"Gavrieli","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2021.12.025_b0110","first-page":"1111","article-title":"Nasopharyngeal pneumococcal carriage during childhood community-acquired alveolar pneumonia: Relationship between specific serotypes and coinfecting viruses","volume":"215","author":"Greenberg","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.12.025_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2021.12.025_b0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/aje\/kwy219","article-title":"Association between the decline in pneumococcal disease in unimmunized adults and vaccine-derived protection against colonization in toddlers and preschool-aged children","volume":"188","author":"Weinberger","year":"2019","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21016364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:07:49Z","timestamp":1759403269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21016364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21016364"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}